233 related articles for article (PubMed ID: 34722523)
1. Tau Stabilizes Chromatin Compaction.
Rico T; Gilles M; Chauderlier A; Comptdaer T; Magnez R; Chwastyniak M; Drobecq H; Pinet F; Thuru X; Buée L; Galas MC; Lefebvre B
Front Cell Dev Biol; 2021; 9():740550. PubMed ID: 34722523
[TBL] [Abstract][Full Text] [Related]
2. Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression.
Illi B; Nanni S; Scopece A; Farsetti A; Biglioli P; Capogrossi MC; Gaetano C
Circ Res; 2003 Jul; 93(2):155-61. PubMed ID: 12805238
[TBL] [Abstract][Full Text] [Related]
3. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
Mathew OP; Ranganna K; Yatsu FM
Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
[TBL] [Abstract][Full Text] [Related]
4. Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.
To KK; Polgar O; Huff LM; Morisaki K; Bates SE
Mol Cancer Res; 2008 Jan; 6(1):151-64. PubMed ID: 18234970
[TBL] [Abstract][Full Text] [Related]
5. Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
Mishra SK; Mandal M; Mazumdar A; Kumar R
FEBS Lett; 2001 Oct; 507(1):88-94. PubMed ID: 11682064
[TBL] [Abstract][Full Text] [Related]
6. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis of post-translational modifications of human histones.
Beck HC; Nielsen EC; Matthiesen R; Jensen LH; Sehested M; Finn P; Grauslund M; Hansen AM; Jensen ON
Mol Cell Proteomics; 2006 Jul; 5(7):1314-25. PubMed ID: 16627869
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Richon VM; Sandhoff TW; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
[TBL] [Abstract][Full Text] [Related]
11. Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression.
Hu X; Lu X; Liu R; Ai N; Cao Z; Li Y; Liu J; Yu B; Liu K; Wang H; Zhou C; Wang Y; Han A; Ding F; Chen R
J Biol Chem; 2014 Aug; 289(33):23154-23167. PubMed ID: 24939842
[TBL] [Abstract][Full Text] [Related]
12. Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells.
Sharda A; Rashid M; Shah SG; Sharma AK; Singh SR; Gera P; Chilkapati MK; Gupta S
Clin Epigenetics; 2020 Jan; 12(1):4. PubMed ID: 31900196
[TBL] [Abstract][Full Text] [Related]
13. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
14. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo.
Wilson MA; Ricci AR; Deroo BJ; Archer TK
J Biol Chem; 2002 Apr; 277(17):15171-81. PubMed ID: 11821430
[TBL] [Abstract][Full Text] [Related]
16. Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain.
Narayan PJ; Lill C; Faull R; Curtis MA; Dragunow M
Neurobiol Dis; 2015 Feb; 74():281-94. PubMed ID: 25484284
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain.
Im H; Grass JA; Christensen HM; Perkins A; Bresnick EH
Biochemistry; 2002 Dec; 41(51):15152-60. PubMed ID: 12484752
[TBL] [Abstract][Full Text] [Related]
18. Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau.
Jeong H; Shin S; Lee JS; Lee SH; Baik JH; Lim S; Kim YK
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480543
[TBL] [Abstract][Full Text] [Related]
19. Dynamically acetylated histones of chicken erythrocytes are selectively methylated.
Hendzel MJ; Davie JR
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):753-8. PubMed ID: 1996971
[TBL] [Abstract][Full Text] [Related]
20. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein.
Aron JL; Parthun MR; Marcucci G; Kitada S; Mone AP; Davis ME; Shen T; Murphy T; Wickham J; Kanakry C; Lucas DM; Reed JC; Grever MR; Byrd JC
Blood; 2003 Jul; 102(2):652-8. PubMed ID: 12649137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
